Additionally, the Vigil vaccine, an autologous GM-CSF–secreting tumour vaccine with TGF-β knockdown, shows promise in priming anti-tumour immunity and enhancing abscopal potential [6]. This evidence concerns the gene TGFB1 and neoplasm.